E-mail

E-mail a Wiley Online Library Link

L. Fischer, J. Klempnauer, S. Beckebaum, H. J. Metselaar, P. Neuhaus, P. Schemmer, U. Settmacher, N. Heyne, P-A. Clavien, F. Muehlbacher, I. Morard, H. Wolters, W. Vogel, T. Becker, M. Sterneck, F. Lehner, C. Klein, G. Kazemier, A. Pascher, J. Schmidt, F. Rauchfuss, A. Schnitzbauer, S. Nadalin, M. Hack, S. Ladenburger and H. J. Schlitt A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation—PROTECT American Journal of Transplantation 12

Version of Record online: 11 APR 2012 | DOI: 10.1111/j.1600-6143.2012.04049.x

Results from the PROTECT randomized phase II clinical study of liver transplant recipients with good renal function show that the switch from a calcineurin inhibitor to everolimus provides a benefit for renal function after one year.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH